No results displayed.
Inside "Interviews with Patients and Researchers":
@CancerQuest on Twitter:
Related to this page:
Was this page helpful?
|
Page 14 of 45 | <Previous : Next> Jump to Page:

Interview with Dr. Jeffrey Engleman

Dr. Jeffrey Engleman
Assistant Professor, Department of Medicine
Harvard Medical School
Department of Medical Oncology
Massachusetts General Hospital

Dr. Engleman's research focuses on the ways that cancer cells are 'addicted' to signals from mutated genes and the ways that this affects their response to cancer treatment.  Importantly, his work addresses the development of resistance to the drugs used to treat cancer.  He also discusses how students can/should get involved in research.
Image of Dr. Jeffrey Engleman

Questions and Answers

About Dr. Engleman(Time: 19 sec)
Research Motivations(Time: 55 sec)
Oncogene Activation Addiction(Time: 1 min 35 sec)
Model Systems(Time: 1 min 29 sec)
Oncogene Addiction Reversal(Time: 55 sec)
Oncogene Addiction Drug Resistance(Time: 1 min 04 sec)
Developing Resistance(Time: 1 min 45 sec)
Personal Research(Time: 1 min 24 sec)
Resistance Versus Treatment(Time: 57 sec)
Patient Behavior(Time: 1 min 32 sec)
Resistance Cancer Options(Time: 42 sec)
Important Recent Discoveries(Time: 1 min 24 sec)
Research Limitations(Time: 52 sec)
Lab Training(Time: 11 sec)
Student Advice(Time: 40 sec)
Page 14 of 45 | <Previous : Next>
Last Modified: 10/08/2010 Print Email Page Share
Copyright ©2012 Emory University. All rights reserved.
Direct questions and comments to cancerquest@emory.edu.
Disclaimer | Legal Policies | Contact 		Follow @CancerQuest on Twitter
CancerQuest Dictionary
Follow us on: